ATF6 and colorectal carcinoma: Analyses were performed on human samples with advanced CRC, while our model proposes that ATF6 functions as an early driver that initiates metabolic restructuring and ultimately leads to tumorigenesis and therefore making it likely that alterations in LCFAs may not directly reflect disease prognosis at later stages.